In STS, patients receiving ICI immunotherapy exhibited an increased density of cytotoxic tumor-infiltrating T cells, a higher percentage of activated T cells, and tumor-associated macrophages expressing PD-L1. The gene discussed is CD274; the disease is telomere syndrome.